Daniel A. Nguyen

Daniel A. Nguyen

Dermatology
819 Peakwood Dr
Houston, TX 77090

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Journal: Journal of hematology & oncology
Published: April 17, 2026

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 09, 2026

Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia.

Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia.

Journal: Haematologica
Published: September 30, 2025

Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports.

Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports.

Journal: Blood vessels, thrombosis & hemostasis
Published: April 07, 2025

Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial.

Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial.

Journal: The Lancet. Haematology
Published: May 17, 2024

Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors.

Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors.

Journal: Blood cancer journal
Published: July 12, 2023

Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.

Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.

Journal: Cancer
Published: May 25, 2022

Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.

Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.

Journal: American journal of hematology
Published: May 14, 2022

External validation of the HIGH-2-LOW model: A predictive score for venous thromboembolism after allogeneic transplant.

External validation of the HIGH-2-LOW model: A predictive score for venous thromboembolism after allogeneic transplant.

Journal: American journal of hematology
Published: January 11, 2022

Ehlers-Danlos Syndrome: An Analysis of the Current Treatment Options.

Ehlers-Danlos Syndrome: An Analysis of the Current Treatment Options.

Journal: Pain physician
Published: July 26, 2020

Cutaneous leishmaniasis in a 65-year-old North Texas male, treated with cryotherapy: A case report.

Cutaneous leishmaniasis in a 65-year-old North Texas male, treated with cryotherapy: A case report.

Journal: SAGE open medical case reports
Published: April 11, 2019

Hypertension secondary to renal hypoplasia presenting as acute heart failure in a newborn.

Hypertension secondary to renal hypoplasia presenting as acute heart failure in a newborn.

Journal: Clinical hypertension
Published: June 25, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026